In Mendelian randomization (MR) studies, where genetic variants are used as proxy measures for an exposure trait of interest, obtaining adequate statistical power is frequently a concern due to the small amount of variation in a phenotypic trait that is typically explained by genetic variants. A range of power estimates based on simulations and specific parameters for two-stage least squares (2SLS) MR analyses based on continuous variables has previously been published. However there are presently no specific equations or software tools one can implement for calculating power of a given MR study. Using asymptotic theory, we show that in the case of continuous variables and a single instrument, for example a single-nucleotide polymorphism (SNP) or multiple SNP predictor, statistical power for a fixed sample size is a function of two parameters: the proportion of variation in the exposure variable explained by the genetic predictor and the true causal association between the exposure and outcome variable. We demonstrate that power for 2SLS MR can be derived using the non-centrality parameter (NCP) of the statistical test that is employed to test whether the 2SLS regression coefficient is zero. We show that the previously published power estimates from simulations can be represented theoretically using this NCP-based approach, with similar estimates observed when the simulation-based estimates are compared with our NCP-based approach. General equations for calculating statistical power for 2SLS MR using the NCP are provided in this note, and we implement the calculations in a web-based application.
[1]
Jonathan H. Wright,et al.
A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments
,
2002
.
[2]
Jeffrey M. Wooldridge,et al.
Solutions Manual and Supplementary Materials for Econometric Analysis of Cross Section and Panel Data
,
2003
.
[3]
George Davey Smith,et al.
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
,
2008,
Statistics in medicine.
[4]
P. Visscher,et al.
Five years of GWAS discovery.
,
2012,
American journal of human genetics.
[5]
T. VanderWeele,et al.
Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.
,
2011,
International journal of epidemiology.
[6]
J. Hahn,et al.
Estimation with Valid and Invalid Instruments
,
2005
.
[7]
Debbie A Lawlor,et al.
Mendelian randomization: the use of genes in instrumental variable analyses.
,
2011,
Health economics.
[8]
S. Ebrahim,et al.
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
,
2003,
International journal of epidemiology.